Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 51, 3451-3455, July 1, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Studzinski, G. P.
Right arrow Articles by Bhandal, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Studzinski, G. P.
Right arrow Articles by Bhandal, A. K.

Potentiation of 1-ß-D-Arabinofuranosylcytosine Cytotoxicity to HL-60 Cells by 1,25-Dihydroxyvitamin D3 Correlates with Reduced Rate of Maturation of DNA Replication Intermediates1

George P. Studzinski2, Kaladhar B. Reddy, Helen Z. Hill and Amarjit K. Bhandal

Departments of Laboratory Medicine and Pathology [G. P. S., K. B. R., A. K. B.] and Radiology [H. Z. H.], University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark, New Jersey 07103

S-phase-active cytotoxic drugs selectively damage leukemic cells, but the mechanisms of this action are not clear. We have investigated the previously reported potentiation of toxicity of 1-ß-D-arabinofuranosylcytosine (ara-C) to HL-60 cells by the differentiation-inducing steroid, 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], and compared the results with the effects of other drugs which inhibit DNA synthesis. Determination of the intracellular content of the active metabolite of ara-C, ara-CTP, excluded more prolonged retention of the drug as the basis for potentiation of cytotoxicity. Alkaline elution of replicating DNA showed that 1,25(OH)2D3 added with or immediately after ara-C or hydroxyurea reduced the rate maturation of the replicating DNA and resulted in an increased proportion of smaller DNA fragments. However, pretreatment of the cells with 1,25(OH)2D3 inhibited this effect of the drugs on replication of DNA. No direct effect of 1,25(OH)2D3 on replicating DNA could be detected. The results suggest that the early events which initiate cell differentiation may protect an intact DNA replicative machinery from S-phase-active drugs but reduce the rate of DNA maturation once DNA integrity has been compromised by inhibitors of DNA synthesis.

1 Supported by Grant RO1 CA44722 from the National Cancer Institute.

2 To whom requests for reprints should be addressed, at Department of Laboratory Medicine and Pathology, UMDNJ-New Jersey Medical School, 185 South Orange Avenue, Newark, NJ 07103.

Received 12/10/90. Accepted 4/19/91.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
Y. Ji, H. J. Lee, C. Goodman, M. Uskokovic, K. Liby, M. Sporn, and N. Suh
The synthetic triterpenoid CDDO-imidazolide induces monocytic differentiation by activating the Smad and ERK signaling pathways in HL60 leukemia cells.
Mol. Cancer Ther., June 1, 2006; 5(6): 1452 - 1458.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. Itagaki, K. B. Kannan, and C. J. Hauser
Lysophosphatidic acid triggers calcium entry through a non-store-operated pathway in human neutrophils
J. Leukoc. Biol., February 1, 2005; 77(2): 181 - 189.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Chen, Q. Wang, X. Wang, and G. P. Studzinski
Up-Regulation of Egr1 by 1,25-Dihydroxyvitamin D3 Contributes to Increased Expression of p35 Activator of Cyclin-Dependent Kinase 5 and Consequent Onset of the Terminal Phase of HL60 Cell Differentiation
Cancer Res., August 1, 2004; 64(15): 5425 - 5433.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Ji and G. P. Studzinski
Retinoblastoma Protein and CCAAT/Enhancer-Binding Protein {beta} Are Required for 1,25-Dihydroxyvitamin D3-Induced Monocytic Differentiation of HL60 Cells
Cancer Res., January 1, 2004; 64(1): 370 - 377.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Itagaki and C. J. Hauser
Sphingosine 1-Phosphate, a Diffusible Calcium Influx Factor Mediating Store-operated Calcium Entry
J. Biol. Chem., July 18, 2003; 278(30): 27540 - 27547.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Danilenko, Q. Wang, X. Wang, J. Levy, Y. Sharoni, and G. P. Studzinski
Carnosic Acid Potentiates the Antioxidant and Prodifferentiation Effects of 1{alpha},25-Dihydroxyvitamin D3 in Leukemia Cells but Does Not Promote Elevation of Basal Levels of Intracellular Calcium
Cancer Res., March 15, 2003; 63(6): 1325 - 1332.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. Danilenko, X. Wang, and G. P. Studzinski
Carnosic Acid and Promotion of Monocytic Differentiation of HL60-G Cells Initiated by Other Agents
J Natl Cancer Inst, August 15, 2001; 93(16): 1224 - 1233.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Chen and G. P. Studzinski
Expression of the neuronal cyclin-dependent kinase 5 activator p35Nck5a in human monocytic cells is associated with differentiation
Blood, June 15, 2001; 97(12): 3763 - 3767.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1991 by the American Association for Cancer Research.